Protai
Protai57
About
What does Protai do?
Protai has developed an end-to-end AI-based platform designed to comprehensively map the progression of diseases at the protein level. This enhances the observation of cellular functions and aims to revolutionize the drug discovery process.
What is Protai's revenue?
StartupHub estimates Protai's annual revenue at $5.0M (range $2.7M to $7.6M, 64% confidence), based on comparable companies in the sector.
What is Protai's valuation?
StartupHub estimates Protai's effective valuation at $77.8M (range $50.0M to $120.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Protai raised?
Protai has raised a total of $20M in funding. The most recent round on record is Seed.
Where is Protai headquartered?
Protai is headquartered in Tel Aviv, Israel.
When was Protai founded?
Protai was founded in 2021.
What industry does Protai operate in?
Protai operates in Life Sciences, Drug Discovery, Proteomics, Drug Development, AI-Driven Drug Discovery, Biotech.
How many employees does Protai have?
Protai has approximately 28 people on record.
No comments yet. Be the first to share your take.